To support innovative and established research focusing on the causes, prevention and control, screening, treatment, and cure of cancer.
Background
New Jersey has often had the distinction of ranking in the top ten states in the nation for cancer incidence and mortality. The New Jersey State Cancer Registry reports that lung, breast, prostate, and colorectal cancer represent almost all new cancer diagnoses and nearly half of all cancer deaths in the state. To strengthen the battle against cancer, citizens and policy leaders joined together to establish a groundbreaking funding source to fund additional cancer research projects in New Jersey. On January 26, 1995, New Jersey enacted Assembly Bill A1701, establishing the “New Jersey Breast Cancer Research Fund”. The legislation was initiated by the New Jersey Breast Cancer Coalition, Inc. The bill facilitated the conception of the New Jersey Prostate Cancer Research Fund, New Jersey Lung Cancer Research Fund, New Jersey Pediatric Cancer Research Fund, and the New Jersey Ovarian Cancer Research Fund; all of which are listed in the NJ-1040 tax form.
Meeting the Challenge to fund Cancer Research in New Jersey
New Jersey state residents can contribute to the New Jersey Cancer Research Fund through the New Jersey Commission on Cancer Research (NJCCR) website using ePay or donations to the fund by mail to the NJCCR. The fund is administered by NJCCR, which is the only state agency dedicated to funding scientific cancer research.
Administration of the Fund
The Commission administers the Fund at no additional cost to the State.
Grants are awarded through a competitive scientific peer review process.
Research projects focus on the causes, prevention & control, screening, treatment, or cure of breast cancer and may include, but not limited to basic, behavioral, clinical, demographic, epidemiological and psychosocial research (P.L. 1995, Chapter 26).
On average, for every dollar the Commission awards, more then ten dollars are returned to the State for continued research.